Pharming Group (PHGUF)

Pharming Group Financial Statements

Pharming Group Financial Overview

Pharming Group's market cap is currently ―. The company's EPS TTM is $0.032; its P/E ratio is 32.50; Pharming Group is scheduled to report earnings on October 27, 2022, and the estimated EPS forecast is
lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 50.15M$ 46.62M$ 53.71M$ 49.44M$ 41.26M
Gross Profit$ 46.12M$ 41.74M$ 47.98M$ 43.79M$ 37.40M
EBIT$ 20.91M$ 5.61M$ 4.22M$ 2.31M$ 7.15M
EBITDA$ 22.98M$ 7.80M$ 15.81M$ 4.50M$ 9.19M
Net Income Common Stockholders$ 15.74M$ 3.46M$ 2.50M$ -673.87K$ 4.85M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 154.79M$ 158.04M$ 158.30M$ 167.07M$ 189.67M
Total Assets$ 393.90M$ 392.80M$ 350.92M$ 345.64M$ 346.23M
Total Debt$ 130.04M$ 131.89M$ 143.24M$ 149.00M$ 157.79M
Net Debt$ -24.76M$ -26.15M$ -15.06M$ -18.07M$ -31.89M
Total Liabilities$ 194.23M$ 198.78M$ 180.53M$ 178.79M$ 179.72M
Stockholders Equity$ 136.25M$ 149.38M$ 166.52M$ 166.85M$ 194.02M
Cash Flow
Free Cash Flow$ 2.81M$ 234.00K$ 9.21M$ 2.38M$ 3.82M
Operating Cash Flow$ 4.00M$ 609.00K$ 15.14M$ 5.01M$ 7.77M
Investing Cash Flow$ 6.39M$ -374.00K$ -6.15M$ -7.07M$ -4.28M
Financing Cash Flow$ -451.00K$ -2.89M$ -1.54M$ -2.17M$ -18.77M
Currency in USD

Pharming Group Earnings and Revenue History

Pharming Group Debt to Assets

Pharming Group Cash Flow

Pharming Group Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis